Search

everythinglearnresearchcommunity

for

Search:↓

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

Recombinant human hair keratin proteins can effectively stop bleeding.

Recombinant human epidermal growth factor is versatile, effective, and safe for long-term skin and mucosal treatments.

Finasteride causes reproductive malformations in male rats.

Kigelia africana fruit extract can prevent and reverse prostate enlargement in rats.

Keratins K6 and K16 are expressed more freely in regenerating mouse skin than K1 and K10.

Keratinocyte growth factor promotes hair growth and reduces hair loss from chemotherapy.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

5-alpha-reductase inhibitors can effectively treat benign prostatic hyperplasia.

The new nanocarriers improve how well water-insoluble drugs dissolve and allow for controlled drug release.

Progesterone significantly reduces neuroblastoma tumor growth without harming healthy cells.

Sirolimus and propranolol may reduce abnormal cell growth and improve lymphatic malformations in children.

Certain derivatives are more effective 5α-reductase type 2 inhibitors than finasteride.

Keratin-gelatin film improves wound healing in pets better than bFGF-gelatin.

CGF and i-PRF are more effective and safer than PRP for treating female pattern hair loss.

Follicle Stimulating Hormone is important for fertility.

The new wound dressing promotes cell growth and healing, absorbs wound fluids well, and is biocompatible.

Finasteride may increase iris billowing risk during surgery, similar to tamsulosin.

Kojyl cinnamate ester derivatives can promote hair growth by increasing adiponectin production in fat tissues.

Latanoprost-loaded nanotransfersomes could help treat hair loss by promoting hair growth.

Birth control pills increase certain receptor activities in female gerbil prostate glands and can lead to prostate changes.

A new protein was made to detect specific skin cell growth receptors and worked in normal skin but not in skin cancer cells.

The treatment helped promote hair growth in men with androgenetic alopecia.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

New compounds may help treat heart disease by activating specific potassium channels.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

A substance called Compound 2g can strongly block STS (a hormone-related enzyme) without affecting estrogen levels, making it potentially good for treating breast cancer.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.